CTS Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTS research report →
Range $67 – $80
Price Chart
About the company
CTS Corporation is a global enterprise specializing in the production and distribution of vital electronic components, such as sensors, actuators, and connectivity solutions, with operations spanning North America, Europe, and Asia. Its extensive product line includes specialized sensors and actuators developed for both passenger and commercial vehicles. Additionally, CTS provides advanced connectivity components crucial for telecommunications infrastructure, information technology networks, and other high-speed applications.
- CEO
- Pratik Trivedi
- IPO
- 1980
- Employees
- 3,492
- HQ
- Lisle, IL, US
Get TickerSpark's AI analysis on CTS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.57B
- P/E
- 22.36
- Fwd P/E
- 19.62
- PEG
- 0.77
- P/S
- 2.87
- P/B
- 2.80
- EV/EBITDA
- 11.24
- Div Yield
- 0.28%
- Gross Margin
- 40.27%
- Op Margin
- 16.81%
- Net Margin
- 12.93%
- ROE
- 13.02%
- ROIC
- 9.12%
Latest fiscal year · YoY change
- Revenue
- $542.16M+5.2%
- Gross Profit
- $208.73M+10.9%
- Op Income
- $84.74M
- Net Income
- $65.32M+12.4%
- EPS
- $2.21+15.7%
- OCF Growth
- +2.8%
- FCF Growth
- +7.1%
- 52W High
- $69.55
- 52W Low
- $40.39
- 50D MA
- $58.58
- 200D MA
- $58.03
- Beta
- 0.94
- RSI (14)
- 39
- Avg Volume
- 225.25K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
CTS reported a strong third quarter with record margins and EPS, raised full-year guidance, and highlighted the strategic Millar acquisition to deepen its move into medical and other diversified end markets.· October 27, 2026
- Revenue rose 5% year over year to $150 million, with diversified end markets up 7% and making up 60% of sales.
- Adjusted gross margin reached a record 42.2%, adjusted EBITDA margin was 24.7%, and adjusted diluted EPS was a record $0.77.
- Book-to-bill was 1.18 overall, led by diversified bookings at 1.3; A&D was especially strong at 1.91.
- Management raised full-year 2026 guidance to sales of $580 million-$590 million and adjusted diluted EPS of $2.78-$2.88.
- Millar was presented as a strategic, cash-funded acquisition that should be gross-margin accretive and EPS accretive in the second half of 2027.
Third-quarter sales were $149.6 million, up 5% year over year and up 3% sequentially. Adjusted gross margin was 42.2%, up 330 basis points year over year and about 70 basis points sequentially; adjusted EBITDA margin was 24.7%, up about 90 basis points year over year; and adjusted diluted EPS was $0.77 versus $0.60 in the prior-year quarter. Operating cash flow was $44 million, capex was $2.4 million, and free cash flow was about $41 million; cash ended at $144 million and borrowings at $55 million. For the full year 2026, management raised guidance to sales of $580 million-$590 million and adjusted diluted EPS of $2.78-$2.88, and said the tax rate should be 20%-22% excluding discrete items. Management also said Millar is expected to generate about $30 million in annual revenue, be accretive to gross margin, and become EPS accretive in the second half of 2027.
Pratik Trivedi framed the quarter as evidence that CTS is executing its strategy of shifting toward a more diversified, higher-value portfolio. He emphasized strong growth in diversified end markets, improved earnings quality, and the Millar acquisition as another step toward more exposure to medical and industrial markets. His tone was upbeat and confident, while still noting transportation remains constrained by broader market uncertainty.
Ashish Agrawal focused on the quality of the quarter's financial performance and cash generation. He cited adjusted gross margin of 42.2%, adjusted EBITDA margin of 24.7%, adjusted EPS of $0.77, operating cash flow of $44 million, capex of $2.4 million, and free cash flow of about $41 million. He also said foreign exchange helped sales by about $0.5 million and EPS by about $0.04, noted a quarter-end cash balance of $144 million versus $55 million of borrowings, and said the company repurchased 57,000 shares for about $3.4 million while keeping $75 million available under the buyback program.
Analysts focused heavily on Millar, asking about EBITDA margin accretion, historic growth, customer concentration, and financing. Management said gross margin should be accretive, EBITDA should be positive but may not be accretive at the beginning, and EPS accretion should come in the second half of 2027; the deal was funded entirely with cash. On operations, they said Millar's customer concentration would not materially change CTS's overall profile, and that the acquisition should not force sudden structural changes or major changes to R&D spending. Questions on transportation and A&D led management to say transportation growth was modest and mostly tied to commercial vehicles, while A&D remains lumpy but backed by a healthy backlog and over-time revenue recognition.
The bull case from the call is that CTS is improving its mix toward diversified, higher-margin end markets while still growing. Management showed confidence in sustained demand in medical, industrial, and A&D, supported by a 1.18 book-to-bill and strong backlogs, and raised full-year guidance. Millar adds a strategic platform in medical and sensing technologies that management believes can accelerate future growth and support further margin expansion over time.
The main risks discussed were transportation softness and the possibility that margins normalize from this quarter's unusually favorable mix. Management said light-vehicle volumes are expected to be flat to modestly down amid tariff, geopolitical, and consumer-demand uncertainty, and the quarter's strong gross margin may not be repeated at the same level in coming quarters. For Millar, management also acknowledged EBITDA may not be accretive immediately and that the business carries some customer concentration, even if not material at the CTS level.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.3%
- Shares Outstanding
- 28.50M
- Float Shares
- 28.02M
of shares held by institutions
282 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CTS, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Michael T. McCaulHouse · TX10 | Sell | Apr 23, 26 | Filing → |
| Michael T. McCaulHouse · TX10 | Sell | Aug 28, 24 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Nov 1, 23 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Nov 1, 23 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Sep 8, 23 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | Sep 8, 23 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | May 24, 23 | Filing → |
| Michael T. McCaulHouse · TX10 | Buy | May 24, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 4.53M | ▲ 25.39K |
| Wasatch Advisors LP | 3.40M | ▼ 197.38K |
| Vanguard Group Inc | 2.74M | ▲ 34.99K |
| Earnest Partners LLC | 1.57M | ▼ 79.22K |
| Vanguard Portfolio Management LLC | 1.29M | ▲ 28.31K |
| Vanguard Capital Management LLC | 1.26M | ▲ 38.50K |
| Dimensional Fund Advisors LP | 1.21M | ▲ 19.08K |
| State Street Corp | 1.21M | ▲ 29.60K |
| Gamco Investors, Inc. Et Al | 1.16M | ▼ 9.48K |
| Brown Advisory Inc | 981.82K | ▼ 39.83K |
| Geode Capital Management, LLC | 944.16K | ▲ 183.25K |
| Harvey Partners, LLC | 545.23K | ▼ 49.17K |
Held by 342 ETFs
Biggest fund positions in CTS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 5, 26 | Zulueta Alfonso G | other | 2,813 |
| Nov 5, 26 | Stone Randy Lee | other | 2,813 |
| Nov 5, 26 | PROFUSEK ROBERT | other | 2,813 |
| Nov 5, 26 | MacKay Kimberly Banks | other | 2,813 |
| Nov 5, 26 | JOHNSON WILLIAM S | other | 2,813 |
| Nov 5, 26 | Dodrill Amy M. | other | 2,813 |
| Nov 5, 26 | Costello Donna | other | 2,813 |
| Oct 30, 26 | O'SULLIVAN KIERAN M | other | 15,860 |
| Aug 25, 26 | Spitler Heather Pehlke | other | 0 |
| Jul 29, 26 | Pacioni Mark R. | other | 531 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CTS coverage
Recent articles, reports, and earnings notes.
No research on CTS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CTS report →CTS Eventim AG & Co. KGaA Q3 Earnings Call Highlights
marketbeat.com · Nov 12
CTS Eventim profit dips as live entertainment revenue falls
reuters.com · Nov 12
CTS vs. WEGZY: Which Stock Is the Better Value Option?
zacks.com · Nov 9
Does CTS (CTS) Have the Potential to Rally 27.3% as Wall Street Analysts Expect?
zacks.com · Nov 9
CTS: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 7
CTS Corporation Declares a Dividend
globenewswire.com · Nov 5
Is CTS (CTS) Stock Outpacing Its Computer and Technology Peers This Year?
zacks.com · Oct 29
CTS Q3 Earnings Call Highlights
marketbeat.com · Oct 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.